Home›Search›European Journal of Cancer, Supplement

European Journal of Cancer, Supplement

Elsevier Ltd · United Kingdom · Est. 1980

ISSN1878-1217

SJR Q3✓ Scopus / SJR✓ DOAJ✓ Open Access

/ 100

High Risk

Score Breakdown

✓ Scopus Q3+12

✓ DOAJ Verified+15

Total37

Journal Impact Factor

Not on record at PubScope. The Journal Impact Factor is published by Clarivate for Web of Science (JCR)–indexed journals. If this journal has one, it appears on the journal’s page ↗

SJR Score

0.428

H-Index

CiteScore

View ↗

Scopus metric · on the journal’s page

Total Works

15,236

Total Citations

18,314

2yr Mean Citedness

0.00

Free JIF alternative

Aims & Scope✦ Inferred from recent articles

This journal focuses on cancer research, particularly exploring the molecular mechanisms of tumor progression and the development of novel therapeutic strategies. It covers topics such as the role of specific enzymes and metabolites in tumorigenesis, the efficacy and cost-effectiveness of treatments for neuroendocrine tumors, and the molecular classification and treatment of ovarian cancers. The journal also examines DNA damage repair pathways and the use of various targeted therapies and inhibitors in cancer treatment.

AI-summarised from recent articles · verify on publisher page →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

weeks to review

Fast · median is 15 wks

SJR Rank

Top 75% in field

General Information

Country / RegionUnited Kingdom

Primary LanguageEnglish

1st Year Published1980

Annual Volume~ 6 articles / year

StatusActive (last: 2021)

Total Publications15,236

Publisher OrgElsevier BV

OA Since2011

Visit Journal Website

Submission Info

Peer ReviewSingle-blind

Review Time~9 weeks

Acceptance Rate—

OA LicenseCC BY, CC BY-NC-ND

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Plagiarism Detection✓ Yes

📦 Long-term Preservation

PorticoCLOCKSS

Think.Check.Submit Compliance

thinkchecksubmit.org

10/12 · 83%

✅

Do you know the journal / publisher?

Elsevier Ltd

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1878-1217

✅

Indexed in a trusted database?

Scopus, DOAJ

✅

Peer review process documented?

Single-blind

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

✅

Long-term digital preservation?

Portico, CLOCKSS

✅

Plagiarism detection in place?

Yes

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Times cited

2012

2013

2014

2015

2016

2020

2021

2026

Source: OpenAlex · Note: citations accumulate over time so older years appear higher

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

OncologyQ3

Cancer ResearchQ4

Subject Classification

Scopus Categories

Cancer ResearchOncology

Research Topics (OpenAlex)

Cancer Treatment and PharmacologyBreast Cancer Treatment StudiesLung Cancer Treatments and MutationsColorectal Cancer Treatments and StudiesHER2/EGFR in Cancer ResearchEstrogen and related hormone effectsCancer Genomics and DiagnosticsRadiopharmaceutical Chemistry and ApplicationsCancer, Hypoxia, and MetabolismAdvanced Breast Cancer Therapies